Services-Misc Health & Allied Services, NEC · SIC 8090

agilon health, inc.

AGL

Watch

Latest revenue

$1.42B

as of 2026-03-31

Latest net income

$48.9M

as of 2026-03-31

Net margin

3.4%

as of 2026-03-31

Price · 5Y

-37.5% / yr 51.3 pts / yr vs S&P 500 90.4% total
Compare:

Live market

delayed ≤15 min
$86.39
7.22%
Market cap
$1.44B
Enterprise value
$1.44B
P/E (trailing)
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$90.48
52-wk low
$0.30
Beta
Shares out
16.7M

5-year trend

What this company does

AI

ITEM 1. Business Overview Our business is transforming healthcare by empowering the primary care physicians (“PCP”) to be the agents for change in the communities they serve. We believe that PCPs, with their intimate patient-physician relationships, are best positioned to drive meaningful change in quality, cost and patient experience when provided with the right infrastructure and payment model. Through our combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, we believe we are poised to revolutionize healthcare for seniors across communities throughout the United States (“U.S.”). We believe our…

AI summary unavailable — showing raw filing excerpt

Generated from AGL's filing dated 2026-02-25

Key risks

AI

Table of Contents ITEM 1A. Risk Factors Summary Risk Factors. Our business is subject to a number of risks, including risks that may prevent us from achieving our business objectives or may adversely affect our business, financial condition, cash flows, and results of operations that you should consider before making a decision to invest in our common stock. These risks include, but are not limited to, the following: Risks Related to Our Business •our history of net losses and the expectation that our expenses will increase in the future; •failure to identify and develop successful new geographies, physician partners and payors, or execute upon our growth initiatives; •success in executing…

AI summary unavailable — showing raw filing excerpt

Generated from AGL's filing dated 2026-02-25

Profitability

Operating margin

-7.8%

62.0%

Net margin

-6.6%

53.7%

Return on equity

-55.2%

39.2%

Return on assets

-30.8%

105.2%

Leverage

Debt / equity

2.68×

64.5%

Long-term debt / equity

0.07×

51.8%

Debt / assets

72.8%

17.5%

Earnings tracker

QuarterRevenueYoYNet incomeYoYNet margin

Q1 2026

2026-03-31

$1.42B-7.3%$48.9M+303.9%3.4%

Q4 2025

2025-12-31

$1.57B+3.1%$-201.0M-90.0%-12.8%

Q3 2025

2025-09-30

$1.44B-1.1%$-110.2M+6.3%-7.7%

Q2 2025

2025-06-30

$1.39B-5.9%$-92.3M-200.7%-6.6%

Q1 2025

2025-03-31

$1.53B-4.5%$12.1M+299.7%0.8%

Q4 2024

2024-12-31

$1.52B$-105.8M-6.9%

Q3 2024

2024-09-30

$1.45B+27.6%$-117.6M-274.1%-8.1%

Q2 2024

2024-06-30

$1.48B+38.7%$-30.7M-4120.4%-2.1%

Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.

Industry trend

Services-Misc Health & Allied Services, NEC · SIC 8090

Your notes

Keep private notes on AGL — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

Insider buying

$352.0K

Insider selling

$0

Net activity

+$352.0K

Distinct insiders

4

Open-market trades over the last 365 days.

Recent transactions

DateInsiderTypeSharesPriceValue
2026-03-09

Denise Zamore

Chief Legal Officer

Purchase5,535
2026-03-09

Girish Venkatachaliah

Chief Technology Officer

Purchase18,448
2026-03-09

Benjamin Shaker

Chief Markets Officer

Purchase18,448
2026-03-02

Benjamin Shaker

Chief Markets Officer

Purchase500,000$0.60$301.1K
2025-11-12

John William Wulf

Director

Purchase81,000$0.63$50.9K

Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.

Who owns AGL

Institutional value

$1.2M

Total shares held

114.0K

Distinct holders

2

-191 vs prior

As of

2026-03-31

Prior: 2025-12-31

Filers with $100M+ AUM disclose holdings 45 days after quarter end.

Top institutional holders

#ManagerSharesValueQoQ changeAction
1WEALTH ENHANCEMENT ADVISORY SERVICES, LLC107.8K$1.2M-215.8K (-66.7%)Trimmed
2IFP Advisors, Inc6.2K$2.0K-1.6K (-20.6%)Trimmed

Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.

Top questions investors are asking

Coming once AGL's latest filing finishes processing.